B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-α response to TLR9 triggering

AIDS Res Hum Retroviruses. 2010 Oct;26(10):1063-74. doi: 10.1089/aid.2009.0288.

Abstract

Each cell in HIV-associated primary central nervous system lymphoma (PCNSL) harbors latent EBV. Notably, the triggering of TLR9, a key event in HIV pathogenesis, also promotes EBV latency and transformation. We hypothesized that because only a minority of HIV-infected patients develops PCNSL, their B cells exhibit aberrant signaling responses to TLR9 triggering. We found higher levels of IL-6, CD80, and CD86 expression at baseline in B cells of those patients than in B cells of matched controls, whereas TNF-a expression was lower. Notably, on TLR9 triggering with CpG 2006, CD80 and TNF-α were up-regulated to a lesser extent in B cells of the former than in those of matched controls. The reduced up-regulation of CD80 might be explained by its higher baseline expression resulting in a more blunted response rather than a specific deficit of the signaling response to TLR9 triggering. However, this cannot explain the blunted TNF-α response, which warrants further investigation. Finally, since increased IL-6 expression is linked to EBV-associated Hodgkin’s lymphoma, the enhanced baseline expression of IL-6 might be important in the pathogenesis of PCNSL in HIV-infected patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • B-Lymphocytes / virology
  • B7-1 Antigen / immunology
  • B7-1 Antigen / metabolism
  • B7-2 Antigen / immunology
  • B7-2 Antigen / metabolism
  • Case-Control Studies
  • Central Nervous System Neoplasms / metabolism*
  • HIV Infections / immunology
  • HIV Infections / metabolism*
  • Herpesvirus 4, Human / pathogenicity
  • Humans
  • Interleukin-6 / immunology
  • Interleukin-6 / metabolism
  • Lymphoma, AIDS-Related / immunology*
  • Male
  • Middle Aged
  • Oligodeoxyribonucleotides / pharmacology
  • Toll-Like Receptor 9 / immunology*
  • Tumor Necrosis Factor-alpha / immunology*
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation

Substances

  • B7-1 Antigen
  • B7-2 Antigen
  • CpG ODN 2006
  • Interleukin-6
  • Oligodeoxyribonucleotides
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Tumor Necrosis Factor-alpha